Independent business intelligence for the life sciences sector
Beremans focuses exclusively on the Life Sciences sector. Within this sector, Beremans’ experience is both broad and deep, encompassing activities from fundamental research at the laboratory bench to board level functions such as licensing and corporate development. Further detail on Beremans’ major fields of expertise, and some examples illustrating Beremans’ recent experience, may be found here.
Within the Life Sciences sector, Beremans provides services to fund managers, venture capital organisations, biopharma executives, corporate finance advisors and similar parties. These services include independent investment research (company analysis, due diligence), strategic opportunity analysis (M&A) and market research (assessment of product potential). More information on Beremans’ services may be found here.
Beremans produces occasional reports on topics relevant to the Life Sciences sector. These may include analyses of technologies, of clinical needs and of market dynamics in a given segment of the Life Sciences sector. Further details regarding our bespoke and publicly available reports may be found here.
A key service provided by Beremans is the identification and facilitation of M&A opportunities in fast-moving, high-value segments of the Life Sciences sector. Follow this link for access to recent Strategic Opportunity papers published by Beremans.
From time to time, Beremans interviews key individuals critically involved in building the next generation of biopharmaceutical companies. Follow this link for access to recent interview transcripts published by Beremans.